Double refractory chronic lymphocytic leukemia: clinical scenarios and therapeutic strategies MED CLIN-BARCELONA
Comorbidities, medication use, and overall survival in eight cancers: a multinational cohort study of 1.7 million patients across Europe LANCET REG HEALTH-EU
European Expert Recommendations on Teclistamab Management for Relapsed or Refractory Multiple Myeloma CL LYMPH MYELOM LEUK
In Vitro Evidence of Therapy-Induced Suppression of Prothrombotic and Proinflammatory Phenotypes in Severe COVID-19 THROMB HAEMOSTASIS